Is NCT04873050 recruiting in Baton Rouge, LA?

Yes, NCT04873050 is currently recruiting participants at its Baton Rouge, LA location. This pre diabetes clinical trial is actively enrolling qualified participants.

How do I join the pre diabetes clinical trial in Baton Rouge?

To join this clinical trial in Baton Rouge, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Baton Rouge clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Pre Diabetes Clinical Trial in Baton Rouge, LA

About This Pre Diabetes Study in Baton Rouge

The purpose of the study is to determine the efficacy of semaglutide 1mg (Ozempic®) to aid recently postpartum women with dysglycemia and a history of GDM to regress to normoglycemia; thereby filling a gap in efficacious pharmacologic intervention options for clinicians to support postpartum diabetes recovery and reduce future risk of T2DM in young women.

Sponsor: Woman's

Who Can Participate

Inclusion Criteria

18 - 45 years old (inclusive)

History of gestational diabetes in most recent pregnancy

6 months - 10 years postpartum

BMI ≥ 25 kg/m2

Use of long-acting reversible contraception or bilateral tubal ligation

Dysglycemia as determined by glycemic response to 75g, 2-hour OGTT: either impaired fasting glucose (IFG), impaired glucose tolerance (IGT), or both (IFG/IGT):

Fasting glucose 100-125mg/dL (inclusive) and/or

120 minute glucose 140-199mg/dL (inclusive)

Willingness to maintain physical activity level throughout study duration

Willingness to standardize diet for 3 days prior to OGTT

Ability to provide informed consent before any trial-related activities

Exclusion Criteria

Body weight \> 350lb

Pregnant or the intention of becoming pregnant or not using adequate contraceptive measures.

Breastfeeding within 3 months of screening visit 1

Post-menopausal

Desiring pregnancy within study participation period or two months after participation ends (i.e. 10 months from enrolment)

Use of tobacco products within past 6 months

Substance or alcohol abuse

Presence of significant systemic disease including: diabetes mellitus (type 1 or type 2), cardiac disease (e.g. congestive heart failure), renal impairment (e.g. serum creatinine levels ≥ 1.4 mg/dL or eGFR \< 60), hepatic disease (including viral hepatitis, toxic hepatic damage, jaundice of unknown aetiology, or abnormal liver function tests), pancreatitis, uncontrolled thyroid disease (e.g. documented abnormal TSH), adrenal disease (including Cushing's syndrome, congenital adrenal hyperplasia), hyperlipidemia (fasting triglycerides \> 399mg%), untreated or poorly controlled hypertension (resting blood pressure \>159/94 mmHg)

History of or presence of: eating disorder, malignant disease requiring chemotherapy, or debilitating psychiatric disorder such as psychosis or neurological condition that could confound outcome variables

History of bariatric surgery

Use of medications for glucose regulation: insulin (e.g. Humalog, Novolog, Humulin), pramlintide, metiglinides, metformin, thiazolidinediones, GLP-1 receptor agonists, DPP-4 inhibitors, SGLT2 inhibitors within four weeks of screening visit 1

Use of medications for anti-obesity or weight loss within four weeks of screening visit 1

Use of medications known to exacerbate glucose dysfunction (such as isotretinoin or corticosteroids) within four weeks of screening visit 1

Known or suspected allergy to trial medication, excipients, or related products

Contraindications to study medications: patients with a personal or family history of medullary thyroid cancer or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Current or recent past (within 3 months) participation in another experimental drug trial

Previous randomization in this trial

Receipt of any investigational drug within 6 months prior to this trial

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Baton Rouge?

Yes, this clinical trial (NCT04873050) has an active research site in Baton Rouge, LA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pre Diabetes Treatment Options in Baton Rouge, LA

If you're searching for pre diabetes treatment options in Baton Rouge, LA, this clinical trial (NCT04873050) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Baton Rouge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pre diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pre diabetes clinical trials near you to find additional studies recruiting in your area.

Pre Diabetes Clinical Trial in Baton Rouge, LA

Expert Care in Baton Rouge

IRB Approved

No-Cost Care

Apply for This Baton Rouge Location

Why Participate?

Simple Process